BioPolaris Industry Reports

	Research Index \| Publishers \| My Account \| Contact Us \| About MindBranch
	Welcome Guest (Login/Register) \| 0 items

Advanced Search > | Tips >

Contact a
Research Assistant
US 800-774-4410
or +1-240-747-3094
Search Assistance >

Matching Industries

Biotechnology1

Pharmaceutical4

About MindBranch

Government Services
Press Releases
Our Publishers
Our Clients
Publisher Sign-Up

Home > About MindBranch > Market Research Publishers

BioPolaris

BioPolaris is a lifescience market research company. It offers the most current intelligence reports covering biotechnology, pharmaceutical and medical companies, their technologies and investigational products. Our customers are investors, companies and professionals worldwide.

5 publications

	Title	Published	Price
1	Stem Cell Therapies: Commercial R & D Mega Pipeline Report	Nov 2009	$4,500.00
	Stem cell therapies are relatively new and fast developing field. There is huge interest among general public, patients suffering from incurable and difficult to cure diseases, professionals, scientists and investors in this area of therapeutic more... Published by: BioPolaris \| Search inside this report

2	Diabetes R & D Pipeline: GLP-1 Agonists, Analogs and Allosteric Modulators	Oct 2009	$950.00
	The worldwide market for anti-diabetic therapeutic products is large and highly competitive. The global antidiabetic market is estimated to be over $24 billion in 2008. The largest players in this market are AstraZeneca plc (UK), more... Published by: BioPolaris \| Search inside this report

3	Diabetes R & D Pipeline: PPAR Agonists	Oct 2009	$650.00
	Diabetes is a chronic disease that may reduce life expectancy by as much as 15 years because high blood glucose levels can damage blood vessels and nerves. The International Diabetes Institute (Australia) estimates that direct more... Published by: BioPolaris \| Search inside this report

4	Diabetes R & D Pipeline: Cell and Stem Cell Therapies	Sep 2009	$650.00
	This report addresses the recent advances in research and development of pancreatic islet cell and stem cell therapies for the treatment diabetes, primarily of type 1 diabetes. The report features 10 cell and stem cell more... Published by: BioPolaris \| Search inside this report

5	Diabetes R & D Pipeline Report: DPP-4 Inhibitors	Sep 2009	$750.00
	With increasing incidence and prevalence of diabetes, not only in developed countries but also in countries of the third world, demand for cheap and efficient products for the treatment of diabetes is growing. With perspective more... Published by: BioPolaris \| Search inside this report

	Title	Published	Price

Phone: 800-774-4410 (US) or +1-240-747-3094 (Int'l)
Hours: 7:00 a.m. to 7:00 p.m. EST Monday through Friday
Email: support@mindbranch.com